(Q55463889)

12 July 2018

title

Wnt/beta-Catenin pathway in human glioma: expression pattern and clinical/prognostic correlations. (English)

1 reference

12 July 2018

author name string

Ce Liu

1

1 reference

12 July 2018

Yanyang Tu

2

1 reference

12 July 2018

Xiaoyang Sun

3

1 reference

12 July 2018

Jian Jiang

4

1 reference

12 July 2018

Xiaodong Jin

5

1 reference

12 July 2018

Xiangfei Bo

6

1 reference

12 July 2018

Zhengming Li

7

1 reference

12 July 2018

Aimiao Bian

8

1 reference

12 July 2018

Xiaodong Wang

9

1 reference

12 July 2018

Dai Liu

10

1 reference

12 July 2018

Zhengmei Wang

11

1 reference

12 July 2018

Lianshu Ding

12

1 reference

12 July 2018

publication date

31 August 2010

1 reference

12 July 2018

Clinical and Experimental Medicine

published in

1 reference

12 July 2018

volume

11

1 reference

12 July 2018

issue

2

1 reference

12 July 2018

page(s)

105-112

1 reference

12 July 2018

https://scigraph.springernature.com/pub.10.1007/s10238-010-0110-9

exact match

0 references

cites work

Prognostic significance of molecular markers and extent of resection in primary glioblastoma patients

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0110-9

Identification of proteins involved in neural progenitor cell targeting of gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0110-9

The promise and perils of Wnt signaling through beta-catenin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0110-9

Immunohistochemical and sequencing analyses of the Wnt signaling components in Japanese anaplastic thyroid cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0110-9

Deregulated Wnt/beta-catenin program in high-risk neuroblastomas without MYCN amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0110-9

Sulindac targets nuclear beta-catenin accumulation and Wnt signalling in adenomas of patients with familial adenomatous polyposis and in human colorectal cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0110-9

Aberrant nuclear localization of beta-catenin without genetic alterations in beta-catenin or Axin genes in esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0110-9

Proliferation, but not apoptosis, is associated with distinct beta-catenin expression patterns in non-small-cell lung carcinomas: relationship with adenomatous polyposis coli and G(1)-to S-phase cell-cycle regulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0110-9

Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0110-9

ILK over-expression in human colon cancer progression correlates with activation of beta-catenin, down-regulation of E-cadherin and activation of the Akt-FKHR pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0110-9

Wnt signaling promotes oncogenic transformation by inhibiting c-Myc-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0110-9

Wnt1 overexpression promotes tumour progression in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0110-9

Up-regulation of Wnt-1 and beta-catenin production in patients with advanced metastatic prostate carcinoma: potential pathogenetic and prognostic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0110-9

Beta-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0110-9

Large scale molecular analysis identifies genes with altered expression in salivary adenoid cystic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0110-9

Activation of Wnt/beta-catenin/Tcf signaling pathway in human astrocytomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0110-9

Downregulation of Wnt2 and beta-catenin by siRNA suppresses malignant glioma cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0110-9

The Wnt signaling pathway and its role in tumor development

21 January 2018

1 reference

12 December 2020

Wnt signaling and cancer

1 reference

12 December 2020

β-Catenin overexpression in malignant glioma and its role in proliferation and apoptosis in glioblastma cells.

1 reference

12 December 2020

Wnt-1 but not epidermal growth factor induces beta-catenin/T-cell factor-dependent transcription in esophageal cancer cells

1 reference

12 December 2020

Alterations and correlations of the components in the Wnt signaling pathway and its target genes in breast cancer.

1 reference

12 December 2020

Aberrant expression of beta-catenin, Pin1 and cylin D1 in salivary adenoid cystic carcinoma: relation to tumor proliferation and metastasis.

1 reference

12 December 2020

Clinical and immunohistochemical prognostic factors in adult glioblastoma patients.

1 reference

12 December 2020

[Significance of beta-catenin and Cyclin D1 express in glioma].

1 reference

12 December 2020

Effect of WNT-1 on beta-catenin expression and its relation to Ki-67 and tumor differentiation in oral squamous cell carcinoma.

1 reference

12 December 2020

10.1007/S10238-010-0110-9

Identifiers

DOI

1 reference

12 July 2018

Dimensions Publication ID

0 references

1 reference

12 July 2018